Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 482-486, February 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whalley, C. E.
Right arrow Articles by Epstein, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whalley, C. E.
Right arrow Articles by Epstein, S. S.

In Vivo and Microsomal Metabolism of the Pancreatic Carcinogen N-Nitrosobis(2-oxopropyl)amine by the Syrian Golden Hamster1

Christopher E. Whalley, Zafar M. Iqbal and Samuel S. Epstein

The School of Public Health, University of Illinois at the Medical Center, Chicago, Illinois 60680

N-Nitrosobis(2-oxopropyl)amine (BOP), a ß-oxidized metabolite of di-n-propylnitrosamine, is a potent carcinogen of the pancreas in Syrian golden hamsters. In the present studies, we investigated the in vivo metabolism of BOP in hamsters as well as its in vitro metabolism by the hamster pancreatic, liver, kidney, and lung microsomes. Data are also presented utilizing high-pressure liquid chromatography separation methodology for the BOP metabolites, N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine (HPOP) and N-nitrosobis(2-hydroxypropyl)amine (BHP).

Groups of three hamsters given BOP (50 mg/kg i.p.) were sacrificed at intervals between 15 and 240 min, and the pancreas, liver, lung, kidney, and other tissues were removed; blood and urine were also collected. At 15 min, HPOP levels were highest in the pancreas (34 µg/g) followed by liver, lung, and kidney (14 to 16 µg/g) and testes and brain (5 to 8 µg/g). However, BHP levels were significantly lower (liver and kidney, 5 to 7 µg/g) or undetectable (pancreas). Plasma levels of HPOP and BHP were 25 and 4 µg/ml, respectively. Both HPOP and BHP (when measurable) decreased with time. The half-life of HPOP in the pancreas (75 min) was longer than that in other tissues (45 to 57 min). However, the half-life of BHP in plasma and tissues was 72 to 90 min, which was similar to the HPOP half-life in the pancreas. HPOP and BHP levels in the urine increased with time, reaching a maximum of 217 µg HPOP per ml at 1 hr and 168 µg BHP per ml at 4 hr. Microsomal preparations from selected tissues were capable also of converting BOP to HPOP; the rate of HPOP formation by the pancreatic microsomes was approximately 4.7 ng/mg protein per min, which was significantly lower than the rates in the liver, kidney, and lung microsomes.

The presence of HPOP, a presumed proximate carcinogenic metabolite of BOP, in the pancreas appears to be of significance in the understanding of specificity of BOP for the hamster pancreas.

1 This work was supported by National Cancer Institute (NIH) Grant CA-20914.

Received 7/10/80. Accepted 11/ 4/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.